Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Lexston Mining Corporation
C.LEXT
Alternate Symbol(s):
LEXTF
Metals & Mining
Industrial Metals & Minerals
Lexston Mining Corporation engages in the acquisition and exploration of mineral properties in Canada. It holds a 100% interest in the Dory property consisting of four non-surveyed contiguous mineral claims totaling 1,348 hectares located within the Alberni Mining Division of British Columbia. The company is based in Vancouver, Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (CSE:LEXT)
New Post
View:
Posts & Comments
Threaded Posts
(5)
•••
howestreetbull
X
Post by
howestreetbull
on Jan 22, 2025 9:16am
or not CSE Bulletin: Consolidation - Lexston Mining Corporat
CSE Bulletin: Consolidation - Lexston Mining Corporation (LEXT)
(0)
•••
DaveyG58
X
Post by
DaveyG58
on Jan 08, 2025 10:44am
This looks like will head back to .10 again. Low float
This is an easy win.
(5)
•••
howestreetbull
X
Post by
howestreetbull
on Jan 07, 2025 2:52pm
Looking Better!!!
Averaging trade, December 17, 2024 Buy more $LEXT at 0.02 %125
(0)
•••
DaveyG58
X
Post by
DaveyG58
on Jan 07, 2025 2:14pm
Looks intresting here now. Bids rolling in.
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jan 31, 2022 8:47am
Granted Section 56 Exemption from Health Canada
Vancouver – TheNewswire - British Columbia, January 31, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTCQB:LEXTF
...more
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jan 14, 2022 7:20pm
Comments On Recent Market Activity
Vancouver, British Columbia – TheNewswire - January 14, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF
...more
(1)
•••
cashmoney88
X
Post by
cashmoney88
on Sep 09, 2021 7:25pm
Shroom Stock About To Fly!
Been waiting on this since it was first listed! Today it woke right up! They hired a PR firm so im guessing news is right around the corner! Tight float and somebody was obviously accumulating today!
...more
(1)
•••
cashmoney88
X
Post by
cashmoney88
on Jul 13, 2021 9:09am
News!!
https://ceo.ca/@thenewswire/lexston-life-sciences-corp-health-canada-section-56
(1)
•••
cashmoney88
X
Comment by
cashmoney88
on Jul 08, 2021 4:58pm
RE:Hello World... anyone watching this one?
Looks to me like they are getting ready to run it! I think the float is pretty small....which means it could run very fast! Hopefully more news about there venture into the shroom market! There
...more
(1)
•••
PsychedUp
X
Post by
PsychedUp
on Jul 07, 2021 4:18pm
Hello World... anyone watching this one?
This has had an interesting first couple of weeks. Looks like some great potential. It gaps up quickly on little volume. I'm in, lets rock! The Psych market is going to be hot for at least another
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
A Company Focused on Developing Functional Healthier “Better For You” Foods
Building Momentum in One of the World's Most Prospective Copper Regions
Sorrento Resources Provides Update on Exploration on Rodgers Cove Project, Newfoundland
A tungsten producer and developer in Portugal, South Korea & Spain on track to become a top supplier
DiagnosTear Announces Clinical Study to Advance Analytical Validation & FDA Submission Pathway of TeaRx(TM)